Prof. Dr. Magd Zakaria an eminent professor of neurology at Ain Shams University has published in the Lancet a breakthrough in diagnosis of the blinding "optic neuritis". In collaboration with 100 researchers, the most recent diagnosis criteria were laid down........
Read More
Five doctors from the Department of Diagnostic and Interventional Radiology at Ain Shams University Hospitals won the 3rd place in a program affiliated with Siemens International, which aimed to generate ideas for developing the infrastructure of the health system in Egypt
Read More
The Conference of the Department of Diagnostic, Interventional and Partial Imaging at the Faculty of Medicine, Ain Shams University, under the slogan "An eye on the future" came out with a set of important recommendations, including the focus on scientific research…
Read More
The activities of the annual scientific conference of the Department of Diagnostic, Interventional and Molecular Imaging at the Faculty of Medicine have started in its seventh session. The conference deals with the latest technologies used in the diagnostic radiology field
Read More
The students of the Faculty of Dentistry at the University won third place in the scientific competition attached to the activities of the AEEDC Dubai 2022 conference worldwide, During the reception, prof. Dr. Mohamed Diaa thanks the team supervisor and the team members.
Read More
It was decided to hold protocol ceremonies and rules program for deans, vice-deans of faculties, heads of departments, directors of centers and units, and faculty staff in charge of work, from 2-3 next March at the headquarters of the Institute of Diplomatic Studies....
Read MoreAin Shams University, headed by Prof. Dr. Mahmoud El-Matini launched the Genetic Research and Diagnostic Solutions Project (Lung Matrex), which was launched by the Ain Shams Medical Research Center "MASRI", in a ceremony held at Zafaran Palace.......................
Read MoreFaculty of Medicine, Ain Shams University, launched a new program with participation of Boehringer Ingelheim to train doctors in the diagnosis, treatment and follow-up of cardiomyopathy, which affects 2% globally and causes the death of 50% of diagnosed within five years
Read More
.svg)
